Tetracycline inducible gene manipulation in serotonergic neurons.
The serotonergic (5-HT) neuronal system has important and diverse physiological functions throughout development and adulthood. Its dysregulation during development or later in adulthood has been implicated in many neuropsychiatric disorders. Transgenic animal models designed to study the contribution of serotonergic susceptibility genes to a pathological phenotype should ideally allow to study candidate gene overexpression or gene knockout selectively in serotonergic neurons at any desired time during life. For this purpose, conditional expression systems such as the tet-system are preferable. Here, we generated a transactivator (tTA) mouse line (TPH2-tTA) that allows temporal and spatial control of tetracycline (Ptet) controlled transgene expression as well as gene deletion in 5-HT neurons. The tTA cDNA was inserted into a 196 kb PAC containing a genomic mouse Tph2 fragment (177 kb) by homologous recombination in E. coli. For functional analysis of Ptet-controlled transgene expression, TPH2-tTA mice were crossed to a Ptet-regulated lacZ reporter line (Ptet-nLacZ). In adult double-transgenic TPH2-tTA/Ptet-nLacZ mice, TPH2-tTA founder line L62-20 showed strong serotonergic β-galactosidase expression which could be completely suppressed with doxycycline (Dox). Furthermore, Ptet-regulated gene expression could be reversibly activated or inactivated when Dox was either withdrawn or added to the system. For functional analysis of Ptet-controlled, Cre-mediated gene deletion, TPH2-tTA mice (L62-20) were crossed to double transgenic Ptet-Cre/R26R reporter mice to generate TPH2-tTA/Ptet-Cre/R26R mice. Without Dox, 5-HT specific recombination started at E12.5. With permanent Dox administration, Ptet-controlled Cre-mediated recombination was absent. Dox withdrawal either postnatally or during adulthood induced efficient recombination in serotonergic neurons of all raphe nuclei, respectively. In the enteric nervous system, recombination could not be detected. We generated a transgenic mouse tTA line (TPH2-tTA) which allows both inducible and reversible transgene expression and inducible Cre-mediated gene deletion selectively in 5-HT neurons throughout life. This will allow precise delineation of serotonergic gene functions during development and adulthood.
Department of Molecular Biology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
Tillmann
T
Weber
Insa
I
Renzland
Max
M
Baur
Simon
S
Mönks
Elke
E
Herrmann
Verena
V
Huppert
Frank
F
Nürnberg
Kai
K
Schönig
Dusan
D
Bartsch
D000818:Animals; D017353:Gene Deletion; D055786:Gene Knockout Techniques; D017930:Genes, Reporter / Q000235:genetics; D005821:Genetic Techniques; D059765:Homologous Recombination / Q000187:drug effects; D019426:Integrases / Q000378:metabolism; D007763:Lac Operon / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D009928:Organ Specificity; D059326:Serotonergic Neurons / Q000187:drug effects* / Q000378:metabolism*; D013752:Tetracycline / Q000494:pharmacology*; D015533:Transcriptional Activation / Q000187:drug effects; D014365:Tryptophan Hydroxylase / Q000235:genetics; D001616:beta-Galactosidase / Q000235:genetics
C487802:Tph2 protein, mouse; D014365:Tryptophan Hydroxylase; C045073:Cre recombinase; D019426:Integrases; D001616:beta-Galactosidase; D013752:Tetracycline